Preferences for return of germline genome sequencing results for cancer patients and their genetic relatives in a research setting

6Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Germline genome sequencing (GS) holds great promise for cancer prevention by identifying cancer risk and guiding prevention strategies, however research evidence is mixed regarding patient preferences for receiving GS results. The aim of this study was to discern preferences for return of results by cancer patients who have actually undergone GS. We conducted a mixed methods study with a cohort of cancer probands (n = 335) and their genetic relatives (n = 199) undergoing GS in a research setting. Both groups completed surveys when giving consent. A subset of participants (n = 40) completed semi-structured interviews. A significantly higher percentage of probands thought people would like to be informed about genetic conditions for which there is prevention or treatment that can change cancer risk compared to conditions for which there is no prevention or treatment (93% [311] versus 65% [216]; p < 0.001). Similar results were obtained for relatives (91% [180] versus 61% [121]; p < 0.001). Themes identified in the analysis of interviews were: (1) Recognised benefits of GS, (2) Balancing benefits with risks, (3) Uncertain results are perceived as unhelpful and (4) Competing obligations. While utility was an important discriminator in what was seen as valuable for this cohort, there was a variety of responses. In view of varied participant preferences regarding return of results, it is important to ensure patient understanding of test validity and identify individual choices at the time of consent to GS. The nature and value of the information, and a contextual understanding of researcher obligations should guide result return.

References Powered by Scopus

Using thematic analysis in psychology

110426Citations
N/AReaders
Get full text

Using the framework method for the analysis of qualitative data in multi-disciplinary health research

6472Citations
N/AReaders
Get full text

Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): A policy statement of the American College of Medical Genetics and Genomics

1352Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMT

13Citations
N/AReaders
Get full text

Landscape of germline cancer predisposition mutations testing and management in pediatrics: Implications for research and clinical care

9Citations
N/AReaders
Get full text

Patient perspectives on testing for clonal hematopoiesis of indeterminate potential

7Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Best, M. C., Butow, P., Savard, J., Jacobs, C., Bartley, N., Davies, G., … Newson, A. J. (2022). Preferences for return of germline genome sequencing results for cancer patients and their genetic relatives in a research setting. European Journal of Human Genetics, 30(8), 930–937. https://doi.org/10.1038/s41431-022-01069-y

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 2

100%

Readers' Discipline

Tooltip

Medicine and Dentistry 1

33%

Economics, Econometrics and Finance 1

33%

Business, Management and Accounting 1

33%

Article Metrics

Tooltip
Mentions
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free